Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Down Syndrome | 18 | 2024 | 898 | 1.770 |
Why?
|
Alzheimer Disease | 15 | 2024 | 8579 | 0.590 |
Why?
|
tau Proteins | 8 | 2024 | 2091 | 0.410 |
Why?
|
Influenza A Virus, H1N1 Subtype | 5 | 2014 | 445 | 0.360 |
Why?
|
Amyloid beta-Peptides | 9 | 2024 | 3835 | 0.320 |
Why?
|
Neurofilament Proteins | 3 | 2021 | 336 | 0.230 |
Why?
|
Cerebrovascular Disorders | 2 | 2022 | 1475 | 0.230 |
Why?
|
Blood Transfusion | 2 | 2020 | 1299 | 0.220 |
Why?
|
Influenza, Human | 5 | 2014 | 1517 | 0.220 |
Why?
|
Nerve Degeneration | 2 | 2022 | 748 | 0.210 |
Why?
|
Amyloid | 2 | 2024 | 840 | 0.170 |
Why?
|
Apolipoprotein E4 | 2 | 2023 | 706 | 0.160 |
Why?
|
Infarction | 1 | 2020 | 248 | 0.160 |
Why?
|
Echovirus Infections | 1 | 2018 | 7 | 0.160 |
Why?
|
Foot-and-Mouth Disease | 1 | 2018 | 7 | 0.160 |
Why?
|
Hypertrophy | 1 | 2020 | 559 | 0.160 |
Why?
|
Enterovirus Infections | 1 | 2018 | 74 | 0.150 |
Why?
|
Antihypertensive Agents | 2 | 2017 | 2018 | 0.150 |
Why?
|
Positron-Emission Tomography | 7 | 2024 | 6475 | 0.140 |
Why?
|
Postoperative Hemorrhage | 1 | 2020 | 415 | 0.140 |
Why?
|
Medication Therapy Management | 1 | 2017 | 130 | 0.130 |
Why?
|
Blood Loss, Surgical | 1 | 2020 | 636 | 0.130 |
Why?
|
Medication Adherence | 2 | 2017 | 2166 | 0.130 |
Why?
|
Nootropic Agents | 1 | 2016 | 157 | 0.120 |
Why?
|
Stilbenes | 1 | 2015 | 155 | 0.110 |
Why?
|
Diuretics | 1 | 2017 | 610 | 0.110 |
Why?
|
Disease Outbreaks | 4 | 2011 | 1762 | 0.110 |
Why?
|
Singapore | 5 | 2014 | 291 | 0.110 |
Why?
|
Fluorine Radioisotopes | 1 | 2015 | 418 | 0.100 |
Why?
|
Apolipoproteins E | 4 | 2023 | 1444 | 0.100 |
Why?
|
Vitamin E | 1 | 2016 | 871 | 0.100 |
Why?
|
Myocardial Contraction | 1 | 2016 | 1516 | 0.090 |
Why?
|
Peptide Fragments | 2 | 2021 | 5105 | 0.090 |
Why?
|
Aniline Compounds | 1 | 2015 | 1069 | 0.080 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2016 | 1047 | 0.080 |
Why?
|
Hypertension, Pulmonary | 1 | 2020 | 1580 | 0.080 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2020 | 1460 | 0.080 |
Why?
|
Hemorrhage | 1 | 2020 | 3414 | 0.080 |
Why?
|
Cross-Sectional Studies | 7 | 2024 | 26063 | 0.080 |
Why?
|
Neurofibrillary Tangles | 1 | 2011 | 457 | 0.080 |
Why?
|
Adult | 21 | 2024 | 220781 | 0.070 |
Why?
|
Czech Republic | 2 | 2017 | 73 | 0.070 |
Why?
|
Middle Aged | 22 | 2023 | 220382 | 0.070 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5491 | 0.070 |
Why?
|
Hypertension | 2 | 2017 | 8527 | 0.070 |
Why?
|
Cerebral Cortex | 1 | 2023 | 5764 | 0.070 |
Why?
|
Severity of Illness Index | 4 | 2018 | 15820 | 0.070 |
Why?
|
Age of Onset | 2 | 2023 | 3302 | 0.070 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2011 | 1170 | 0.070 |
Why?
|
Seasons | 1 | 2011 | 1518 | 0.060 |
Why?
|
Brain | 3 | 2022 | 27060 | 0.060 |
Why?
|
Aging | 2 | 2022 | 8689 | 0.060 |
Why?
|
Blood Pressure Determination | 2 | 2017 | 634 | 0.050 |
Why?
|
Myocardium | 1 | 2016 | 4700 | 0.050 |
Why?
|
Humans | 30 | 2024 | 760437 | 0.050 |
Why?
|
Male | 20 | 2024 | 360035 | 0.050 |
Why?
|
Neurons | 1 | 2022 | 9443 | 0.050 |
Why?
|
Female | 21 | 2024 | 391875 | 0.050 |
Why?
|
Blood Pressure | 1 | 2017 | 8479 | 0.050 |
Why?
|
Viral Load | 1 | 2011 | 3329 | 0.050 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2011 | 2423 | 0.050 |
Why?
|
Time | 1 | 2023 | 544 | 0.050 |
Why?
|
Gliosis | 1 | 2021 | 244 | 0.040 |
Why?
|
Infant | 7 | 2020 | 36183 | 0.040 |
Why?
|
Aged | 11 | 2023 | 168840 | 0.040 |
Why?
|
Child, Preschool | 7 | 2020 | 42209 | 0.040 |
Why?
|
Enterovirus B, Human | 1 | 2018 | 47 | 0.040 |
Why?
|
Enterovirus | 1 | 2018 | 67 | 0.040 |
Why?
|
Encephalitis | 1 | 2021 | 438 | 0.040 |
Why?
|
Infant, Newborn | 5 | 2020 | 26280 | 0.040 |
Why?
|
Tissue Survival | 1 | 2016 | 119 | 0.030 |
Why?
|
Dementia | 2 | 2016 | 2679 | 0.030 |
Why?
|
Neuropsychological Tests | 2 | 2020 | 7029 | 0.030 |
Why?
|
Menopause | 1 | 2003 | 1645 | 0.030 |
Why?
|
Young Adult | 7 | 2020 | 59068 | 0.030 |
Why?
|
Pandemics | 2 | 2014 | 8623 | 0.030 |
Why?
|
Age Factors | 3 | 2017 | 18379 | 0.030 |
Why?
|
Heterozygote | 1 | 2021 | 2798 | 0.030 |
Why?
|
Child | 7 | 2020 | 80086 | 0.030 |
Why?
|
Adolescent | 7 | 2020 | 88196 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2017 | 983 | 0.030 |
Why?
|
Myocardial Revascularization | 1 | 2016 | 792 | 0.030 |
Why?
|
Area Under Curve | 1 | 2016 | 1633 | 0.020 |
Why?
|
Necrosis | 1 | 2016 | 1604 | 0.020 |
Why?
|
Proteome | 1 | 2022 | 1861 | 0.020 |
Why?
|
Weight Loss | 1 | 2023 | 2683 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2016 | 1674 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2015 | 1571 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2017 | 15257 | 0.020 |
Why?
|
Treatment Failure | 1 | 2016 | 2642 | 0.020 |
Why?
|
Trinucleotide Repeats | 1 | 2011 | 257 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5236 | 0.020 |
Why?
|
Surgical Procedures, Operative | 1 | 2020 | 1923 | 0.020 |
Why?
|
ROC Curve | 1 | 2016 | 3571 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3818 | 0.020 |
Why?
|
Immunotherapy | 1 | 2024 | 4649 | 0.020 |
Why?
|
Administration, Oral | 1 | 2016 | 4010 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2010 | 6086 | 0.020 |
Why?
|
Hospitalization | 3 | 2014 | 10698 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2020 | 80430 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2024 | 9176 | 0.020 |
Why?
|
Genotype | 1 | 2021 | 12976 | 0.020 |
Why?
|
Patient Compliance | 1 | 2017 | 2689 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2021 | 58859 | 0.020 |
Why?
|
Epidemiologic Studies | 1 | 2010 | 674 | 0.020 |
Why?
|
Gene Dosage | 1 | 2011 | 1218 | 0.020 |
Why?
|
Recovery of Function | 1 | 2016 | 2975 | 0.020 |
Why?
|
Cattle | 1 | 2011 | 3849 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14565 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 36362 | 0.020 |
Why?
|
Odds Ratio | 1 | 2016 | 9639 | 0.010 |
Why?
|
Disease Progression | 1 | 2020 | 13484 | 0.010 |
Why?
|
Prospective Studies | 2 | 2020 | 54339 | 0.010 |
Why?
|
Sex Factors | 1 | 2017 | 10538 | 0.010 |
Why?
|
Cohort Studies | 2 | 2017 | 41366 | 0.010 |
Why?
|
Mental Status Schedule | 1 | 2003 | 314 | 0.010 |
Why?
|
Contrast Media | 1 | 2016 | 5310 | 0.010 |
Why?
|
Risk Factors | 3 | 2016 | 74055 | 0.010 |
Why?
|
RNA, Viral | 1 | 2011 | 2846 | 0.010 |
Why?
|
Quality Improvement | 1 | 2017 | 3798 | 0.010 |
Why?
|
Survival Analysis | 1 | 2014 | 10075 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2016 | 12320 | 0.010 |
Why?
|
Logistic Models | 1 | 2016 | 13240 | 0.010 |
Why?
|
Lung | 1 | 2020 | 9973 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10746 | 0.010 |
Why?
|
Hormones | 1 | 2003 | 867 | 0.010 |
Why?
|
Respiration, Artificial | 1 | 2010 | 2622 | 0.010 |
Why?
|
Hypothyroidism | 1 | 2003 | 667 | 0.010 |
Why?
|
Intelligence | 1 | 2003 | 924 | 0.010 |
Why?
|
United States | 1 | 2024 | 72202 | 0.010 |
Why?
|
Risk Assessment | 1 | 2017 | 23953 | 0.010 |
Why?
|
Comorbidity | 1 | 2010 | 10494 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2010 | 12969 | 0.010 |
Why?
|
Rats | 1 | 2011 | 23712 | 0.010 |
Why?
|
Time Factors | 1 | 2016 | 39947 | 0.010 |
Why?
|
Animals | 2 | 2018 | 168253 | 0.010 |
Why?
|
Phenotype | 1 | 2011 | 16585 | 0.010 |
Why?
|
Alleles | 1 | 2003 | 6908 | 0.010 |
Why?
|
Incidence | 1 | 2010 | 21322 | 0.010 |
Why?
|
Body Mass Index | 1 | 2003 | 12932 | 0.000 |
Why?
|
Case-Control Studies | 1 | 2003 | 22097 | 0.000 |
Why?
|
Depression | 1 | 2003 | 8104 | 0.000 |
Why?
|
Mice | 1 | 2011 | 81402 | 0.000 |
Why?
|
Concepts
(143)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(14)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_